University of California San Francisco
Give to UCSF
Precision Medicine Pillar No. 4: Computational Health Sciences. Computationally intensive approaches are used to analyze and cross-analyze large but discrete collections of data, such as patient health histories and genetic makeup.
Precision Medicine Pillar No. 3: Clinical Discovery. Researchers are taking vast amounts of patient data, often collected through first-ever clinical studies, and putting it into tools like MS Bioscreen that have a direct impact on patient care.
Precision Medicine Pillar No. 2: Basic Discovery. The long path to developing potent new treatments often starts with an observation in the lab that then leads to a question about a fundamental life process.
Precision Medicine Pillar No. 1: Knowledge Network. With an increased ability to harvest information automatically and more powerfully, scientists can find the connections among discoveries that would otherwise go unrecognized.
Today, with a host of tools garnered from precision medicine, patients can benefit from precise and effective therapies for some of the world's most daunting illnesses. <em>UCSF Magazine</em> explores the promise of precision medicine.
With inexpensive genetics kits flooding the market, both consumers — and their doctors — still lack basic information about what to do, if anything, with what they learn about their own genomes.
Researchers at the UCSF-affiliated Gladstone Institutes have discovered how the activation of specific stretches of DNA control the development of uniquely human characteristics.
A UCSF graduate program in complex biology led by Joseph DeRisi, PhD, is being lauded for its creativity with a $100,000 gift.
A UCSF-led team of scientists has discovered that a gene mutation found in some bladder cancers is indicative of low-risk tumors that are unlikely to recur or progress after surgery.
A team of researchers at UCSF is incorporating genomics into a broad group of potential factors that can help clinicians better understand which patients are at greatest risk for persistent postsurgical pain and how to better prevent or treat it.
Researchers have probed deep into the cell’s genome to begin learning the “grammar” that helps determine whether or not a gene gets switched on to make the protein it encodes, advancing efforts to use gene and cell-based therapies to treat disease.
An international study on epilepsy has uncovered 25 new mutations on nine key genes that could pave the way to develop precise therapies for a devastating form of the disorder during childhood.
A UCSF-led team has discovered that vitamin C affects whether genes are switched on or off inside mouse stem cells, suggesting that it may play fundamental role in helping to guide normal development.
A new UCSF study highlights the potential importance of the vast majority of human DNA that lies outside of genes within the cell.